Harold Edward Fleming - 30 May 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ AJ Silver, attorney-in-fact
Issuer symbol
CRSP
Transactions as of
30 May 2024
Transactions value $
$0
Form type
4
Filing time
31 May 2024, 16:15:03 UTC
Previous filing
09 Jun 2023
Next filing
10 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Stock Option (Right to Buy) Award $0 +13,000 $0 13,000 30 May 2024 Common Shares 13,000 $54.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders.